Because the drug acts on gut hormone receptors and slows gastric emptying, the most commonly reported adverse effects in Phase 2 trials include: Nausea (particularly during dose escalation) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally described as mild to moderate in severity and tended to diminish over time
However, it never received FDA approval because the results, while positive, weren't dramatic enough to meet regulatory thresholds for an obesity drug
Iron chelators in cancer therapy
Is Mounjaro Effective for weight loss
We remain committed to ensuring reliable global supplies of this important metabolic therapy. In a Thursday conference call with analysts, the company said that supplies of its generic semaglutide would remain unavailable in India and face disruptions in Canada, where Dr
Folate deficiency can present with similar macrocytosis and should be assessed concurrently